Real Estate / REIT - OfficeUpdated 2026-05-10 22:07 UTC

BME/ARM stock hub

BME/ARM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BME/ARMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

286.6M

Madrid Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BME/ARM

In the news

Latest news · BME/ARM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.8P50 18.7P75 25.9

Trailing P/E2.6

P25 9.7P50 14.2P75 24.9

ROE18.3

P25 1.7P50 4.8P75 9.9

ROIC2.2

P25 1.5P50 2.9P75 4.6

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BME/ARM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

185

Groups with data

Currency

EUR

Showing 185 of 185 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Spain
Country code	ES
Employees	8
Employees Change	-1%
Employees Change Percent	-11.11
Enterprise value	EUR 545.5M
Exchange	Madrid Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	REIT - Office
Isin	ES0105376000
Last refreshed	2026-05-10
Market cap	EUR 286.6M
Price	EUR 11.6
Price currency	EUR
Sector	Real Estate
Sic	6726
Symbol	bme/ARM

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	14.05%
EV Earnings	13.55x
EV/EBIT	37.75x
EV/EBITDA	37.72x
EV/Sales	27.7x
P/B ratio	0.9x
P/E ratio	2.6x
P/S ratio	14.55x
PE Ratio10 Y	16.55x
PE Ratio3 Y	10.67x
PE Ratio5 Y	12.63x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	73.39%
EBITDA Margin	73.45%
Gross margin	83.53%
Gross Profit	EUR 16.4M
Net Income	EUR 40.3M
Net Income Growth	1,779.37%
Net Income Growth Q	6,264.94%
Net Income Growth Quarters	2%
Net Income Growth Years	2%
Net Income Growth3 Y	126.39%
Net Income Growth5 Y	68.57%
Pretax Margin	204.35%
Profit Margin	204.43%
Profitable Years	1
ROA	2.14
Roa5y	2.5
ROCE	3.11
ROE	18.33
Roe5y	7.42
ROIC	2.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	18.2%
Cagr3y	3.71%
Cagr5y	-0.39%
EPS Growth	941.7
EPS Growth Q	3,426.1
EPS Growth Quarters	2
EPS Growth Years	2
EPS Growth3 Y	85.98
EPS Growth5 Y	49.81
OCF Growth	49.73%
OCF Growth Q	-3.92%
OCF Growth10 Y	8.26%
OCF Growth3 Y	34.88%
OCF Growth5 Y	19.84%
Revenue Growth	63.51x
Revenue Growth Q	39.26x
Revenue Growth Years	4x
Revenue Growth3 Y	33.22x
Revenue Growth5 Y	20.45x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.05
Assets	EUR 609.8M
Cash	EUR 13.8M
Debt	EUR 271.6M
Debt EBITDA	EUR 18.78
Debt Equity	EUR 0.85
Equity	EUR 318.3M
Interest Coverage	1.92
Liabilities	EUR 291.5M
Net Cash	EUR -257.8M
Net Cash By Market Cap	EUR -89.96
Net Debt EBITDA	EUR 17.82
Net Debt Equity	EUR 0.81
Tangible Book Value	EUR 317.1M
Tangible Book Value Per Share	EUR 13.03
WACC	3.85

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.13
Net Working Capital	EUR -10.6M
Quick ratio	0.13
Working Capital	EUR -126.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-80.41%
Dividend per share	EUR 0.23
Dividend Yield	1.97%
Payout Ratio	5.01%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	18.19%
200-day SMA	10.47
3Y total return	11.54%
50-day SMA	11.65
50-day SMA vs 200-day SMA	50over200
5Y total return	-1.94%
All Time High	17.16
All Time High Change	-32.4%
All Time High Date	2020-02-18
All Time Low	7.61
All Time Low Change	52.53%
All Time Low Date	2024-02-15
ATR	1.09
Beta	0.21
Beta1y	0.33
Beta2y	0.37
Ch YTD	20.58
High	12.7
High52	14.1
High52 Date	2026-05-07
High52ch	-17.73%
Low	11.5
Low52	8.91
Low52 Date	2025-08-25
Low52ch	30.26%
Ma50ch	-0.43%
Price vs 200-day SMA	10.78%
RSI	48.21
RSI Monthly	59.97
RSI Weekly	61.65
Sharpe ratio	0.51x
Sortino ratio	1.02
Total Return	-78.44%
Tr YTD	20.58
Tr1m	5.65%
Tr1w	-1.69%
Tr3m	9.49%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 14.5M
Operating margin	73.39

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12,136,808%
Shares Insiders	4.84%
Shares Institutions	58.44%
Shares Out	24,703,899
Shares Qo Q	0.09%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	280.4x
Bv Per Share	13.03
Ch1m	5.65
Ch1w	-1.69
Ch1y	18.19
Ch3m	9.49
Ch3y	11.54
Ch5y	-1.94
Ch6m	20.58
Change	-17.73%
Change From Open	-8.66
Close	14.1
Days Gap	-9.93
Depreciation Amortization	11,000
Dollar Volume	22,156
Earnings Date	2026-05-19
EBIT	EUR 14.5M
EBITDA	EUR 14.5M
EPS	EUR 4.46
F Score	3
Financing CF	206,811,000
Fiscal Year End	December
Founded	2,018
Graham Number	36.16742
Graham Upside	211.8
Investing CF	-207,232,000
Is Primary Listing	1
Last Earnings Date	2026-03-03
Last Report Date	2024-12-31
Last Split Date	2026-02-18
Last Split Type	Reverse
Lynch Fair Value	EUR 112
Lynch Upside	861.9
Ma150	10.65
Ma150ch	8.94%
Ma20	11.79
Ma20ch	-1.57%
Net CF	9,497,000
Open	12.7
P OCF Ratio	28.89
Position In Range	8.33
Ppne	580,883,000
Price Date	2026-05-08
Price EBITDA	EUR 19.81
Ptbv Ratio	0.9
Relative Volume	9.77x
Revenue	19,692,000x
Tr6m	20.58%
Volume	1,910

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BME/ARM dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.0%

$0.23 annual per share

Payout ratio

+5.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

Annualized growth of the per-share dividend

Total shareholder yield

-78.4%

Dividend yield + buyback yield combined

Performance

BME/ARM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BME/ARM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+58.4%

Share of float held by funds and institutions

Insider ownership

+4.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

BME/ARM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.2

Neutral momentum band

Price vs 200-day MA

+10.8%

50/200-day relationship not available

Beta (5Y)

0.21

Less volatile than the market

Sharpe ratio

0.51

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BME/ARM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bme/ARM stock rating?

bme/ARM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bme/ARM analysis?

The full report lives at /stocks/bme/ARM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bme/ARM?

The latest report frames bme/ARM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bme/ARM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.